[{"address1": "2617 Bissonnet Street", "address2": "Suite 225", "city": "Houston", "state": "TX", "zip": "77005", "country": "United States", "phone": "346 355 4099", "website": "https://www.alaunos.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive T-cell receptor (TCR) engineered T-cell therapies (TCR-T) to treat multiple solid tumor types. It develops Library TCR-T Cell Theraphy, which is in Phase I/II clinical trial for 12 TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers. The company is also developing hunTR, a human neoantigen TCR discovery engine; and Sleeping Beauty Gene Transfer Platform, a non-viral genetic engineering technology. The company was founded in 2003 and is headquartered in Houston, Texas.", "fullTimeEmployees": 1, "companyOfficers": [{"maxAge": 1, "name": "Mr. Dale Curtis Hogue Jr.", "age": 54, "title": "Interim CEO & Director", "yearBorn": 1970, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melinda  Lackey", "age": 47, "title": "Senior VP of Legal, Administration & Secretary", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 625117, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 3, "overallRisk": 7, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://ir.ziopharm.com/index.cfm", "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.68, "open": 2.69, "dayLow": 2.57, "dayHigh": 2.86, "regularMarketPreviousClose": 2.68, "regularMarketOpen": 2.69, "regularMarketDayLow": 2.57, "regularMarketDayHigh": 2.86, "payoutRatio": 0.0, "beta": -0.743, "forwardPE": -4.383333, "volume": 17724, "regularMarketVolume": 17724, "averageVolume": 478928, "averageVolume10days": 48940, "averageDailyVolume10Day": 48940, "bid": 2.2, "ask": 3.0, "bidSize": 1, "askSize": 1, "marketCap": 4393915, "fiftyTwoWeekLow": 1.31, "fiftyTwoWeekHigh": 14.2, "priceToSalesTrailing12Months": 439.3915, "fiftyDayAverage": 1.9672, "twoHundredDayAverage": 2.4049, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 3120292, "profitMargins": 0.0, "floatShares": 1485930, "sharesOutstanding": 1601250, "sharesShort": 80683, "sharesShortPriorMonth": 51732, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0504, "heldPercentInsiders": 0.16114001, "heldPercentInstitutions": 0.04405, "shortRatio": 0.06, "shortPercentOfFloat": 0.0585, "impliedSharesOutstanding": 1670690, "bookValue": 1.288, "priceToBook": 2.0419257, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -4679000, "trailingEps": -2.92, "forwardEps": -0.6, "lastSplitFactor": "1:10", "lastSplitDate": 1721260800, "enterpriseToRevenue": 312.029, "enterpriseToEbitda": -0.649, "52WeekChange": -0.80225563, "SandP52WeekChange": 0.07995045, "quoteType": "EQUITY", "currentPrice": 2.63, "recommendationKey": "none", "totalCash": 1091000, "totalCashPerShare": 0.681, "ebitda": -4810000, "totalDebt": 0, "quickRatio": 1.584, "currentRatio": 3.981, "totalRevenue": 10000, "revenuePerShare": 0.006, "returnOnAssets": -0.54592, "returnOnEquity": -1.11804, "grossProfits": -352000, "freeCashflow": -3299500, "operatingCashflow": -4971000, "revenueGrowth": 3.0, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -188.75, "financialCurrency": "USD", "symbol": "TCRT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1745615280, "regularMarketTime": 1745611200, "marketState": "CLOSED", "shortName": "Alaunos Therapeutics, Inc.", "longName": "Alaunos Therapeutics, Inc.", "exchange": "NCM", "messageBoardId": "finmb_11686323", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.8656698, "regularMarketPrice": 2.63, "postMarketChangePercent": -4.56274, "postMarketPrice": 2.51, "postMarketChange": -0.12, "regularMarketChange": -0.049999952, "regularMarketDayRange": "2.57 - 2.86", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 478928, "fiftyTwoWeekLowChange": 1.3200002, "fiftyTwoWeekLowChangePercent": 1.0076338, "fiftyTwoWeekRange": "1.31 - 14.2", "fiftyTwoWeekHighChange": -11.57, "fiftyTwoWeekHighChangePercent": -0.8147887, "fiftyTwoWeekChangePercent": -80.22556, "earningsTimestamp": 1743451200, "earningsTimestampStart": 1747139400, "earningsTimestampEnd": 1747657800, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1124890200000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.92, "epsForward": -0.6, "fiftyDayAverageChange": 0.6628001, "fiftyDayAverageChangePercent": 0.3369256, "twoHundredDayAverageChange": 0.22510004, "twoHundredDayAverageChangePercent": 0.09360058, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "ZIOPHARM Oncology, Inc.", "nameChangeDate": "2025-04-25", "cryptoTradeable": false, "displayName": "Alaunos Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-26"}]